Ocugen Inc has a consensus price target of $5.86, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on February 22, 2024, January 24, 2024, and August 31, 2023. With an average price target of $5.33 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 223.29% upside for Ocugen Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/22/2024 | OCGN | Buy Now | Ocugen | $1.65 | 324.32% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
01/24/2024 | OCGN | Buy Now | Ocugen | $1.65 | 324.32% | HC Wainwright & Co. | Swayampakula Ramakanth | $5 → $7 | Maintains | Buy | Get Alert |
08/31/2023 | OCGN | Buy Now | Ocugen | $1.65 | 21.23% | Cantor Fitzgerald | Jennifer Kim | $2.5 → $2 | Maintains | Overweight | Get Alert |
08/23/2023 | OCGN | Buy Now | Ocugen | $1.65 | 203.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | Buy → Buy | Get Alert |
05/08/2023 | OCGN | Buy Now | Ocugen | $1.65 | 142.47% | Chardan Capital | Daniil Gataulin | $3.5 → $4 | Maintains | Buy | Get Alert |
04/17/2023 | OCGN | Buy Now | Ocugen | $1.65 | 203.09% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | → Buy | Get Alert |
04/14/2023 | OCGN | Buy Now | Ocugen | $1.65 | 112.16% | Chardan Capital | Daniil Gataulin | → $3.5 | Maintains | Buy | Get Alert |
03/01/2023 | OCGN | Buy Now | Ocugen | $1.65 | 112.16% | Chardan Capital | Daniil Gataulin | → $3.5 | Upgrade | Neutral → Buy | Get Alert |
03/01/2023 | OCGN | Buy Now | Ocugen | $1.65 | 81.85% | Mizuho | Uy Ear | $5 → $3 | Maintains | Buy | Get Alert |
03/01/2023 | OCGN | Buy Now | Ocugen | $1.65 | 203.09% | HC Wainwright & Co. | Swayampakula Ramakanth | $6 → $5 | Reiterates | → Buy | Get Alert |
08/23/2022 | OCGN | Buy Now | Ocugen | $1.65 | 203.09% | Mizuho | Uy Ear | → $5 | Initiates | → Buy | Get Alert |
08/15/2022 | OCGN | Buy Now | Ocugen | $1.65 | 263.7% | HC Wainwright & Co. | Swayampakula Ramakanth | $7 → $6 | Maintains | Buy | Get Alert |
06/15/2022 | OCGN | Buy Now | Ocugen | $1.65 | 384.94% | Roth Capital | Jonathan Aschoff | → $8 | Reinstates | → Buy | Get Alert |
06/02/2022 | OCGN | Buy Now | Ocugen | $1.65 | 172.78% | Cantor Fitzgerald | Jennifer Kim | → $4.5 | Initiates | → Overweight | Get Alert |
05/12/2022 | OCGN | Buy Now | Ocugen | $1.65 | 324.32% | HC Wainwright & Co. | Swayampakula Ramakanth | $8 → $7 | Maintains | Buy | Get Alert |
02/28/2022 | OCGN | Buy Now | Ocugen | $1.65 | 384.94% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $8 | Maintains | Buy | Get Alert |
06/11/2021 | OCGN | Buy Now | Ocugen | $1.65 | 263.7% | Roth Capital | Zegbeh Jallah | — | Downgrade | Buy → Neutral | Get Alert |
06/11/2021 | OCGN | Buy Now | Ocugen | $1.65 | 506.17% | HC Wainwright & Co. | Swayampakula Ramakanth | — | Maintains | Buy | Get Alert |
05/07/2021 | OCGN | Buy Now | Ocugen | $1.65 | 566.79% | Cantor Fitzgerald | Kristen Kluska | — | Downgrade | Overweight → Neutral | Get Alert |
The latest price target for Ocugen (NASDAQ: OCGN) was reported by HC Wainwright & Co. on February 22, 2024. The analyst firm set a price target for $7.00 expecting OCGN to rise to within 12 months (a possible 324.32% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Ocugen (NASDAQ: OCGN) was provided by HC Wainwright & Co., and Ocugen reiterated their buy rating.
The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.
The last downgrade for Ocugen Inc happened on June 11, 2021 when Roth Capital changed their price target from $10 to $6 for Ocugen Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on February 22, 2024 so you should expect the next rating to be made available sometime around February 22, 2025.
While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a reiterated with a price target of $0.00 to $7.00. The current price Ocugen (OCGN) is trading at is $1.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.